Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. A Laser Resurfacing Device is a skin resurfacing device which uses laser to improve the appearance of skin or treat minor facial flaws by removing layers of skin. GlobalData uses proprietary data and analytics to provide a comprehensive report on the laser resurfacing devices devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the laser resurfacing devices market in New Zealand was Cutera followed by Candela Medical, Lumenis Be, Cynosure, Alma Lasers and Solta Medical.

Laser resurfacing devices are mechanical photo rejuvenating devices. Laser Resurfacing Device includes a handpiece connecting through a cord to the body of the system. Single Technology Laser Devices and Multi Technology Combination Laser Devices are covered under the category. Single Technology Laser Devices are used in the treatment of skin scars, pigmentation, coagulation, skin tightening and others. In Multi Technology Combination Laser Devices, a same console can be used by either having a switch mode or by using different handpieces to treat various indications. Fractional technology is tracked under multi technology combination laser devices. Intense Pulsed Light (IPL) technology is not tracked in this segment. Platform consoles and Handpieces are included in this segment.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the laser resurfacing devices devices market within New Zealand was expected to be over $4m in 2022.

For the latest complete market share analysis of laser resurfacing devices device market in New Zealand, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.